Form D · Biotechnology
Cytek BioSciences, Inc.
Fremont, CA · CIK 0001831915
Offering snapshot reported Nov 10, 2020 · SEC filing
- Reported sold
- $120M Offering amount: $120M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Oct 23, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2020 | Initial | $119,999,935 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-380200
Source: Form D, filed Nov 10, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jack Ball | Director |
| Feng Deng | Director |
| Wenbin Jiang | Director, Executive |
| Andrew Levin | Director |
| Allen Poirson | Director |
| Ming Yan | Director, Executive |
| Jiecheng Zhang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
46107 Landing Parkway
Fremont, CA, 94538
Fremont, CA, 94538